#Whistleblower #HealthcareFraud #DrugPricing
ca.finance.yahoo.com
Big drugmakers must face US overcharge claims on medications for low-income patients
March 17 (Reuters) - A U. S. appeals court on Tuesday revived a whistleblower lawsuit accusing four large drugmakers of defrauding the federal and state governments out of hundreds of millions of dollars by overcharging on medications for low-income and uninsured patients.
#PharmaceuticalIndustry #DrugPricing #HealthcareReform
www.nytimes.com
How TrumpRx Drug Prices Compare With Those in Other Countries
Rebecca Robbins covers the pharmaceutical industry. She oversaw data collection from pharmacies in Canada, Denmark, France, Germany, Italy, Japan, Switzerland and Britain.
#PrescriptionDrugs #HealthcarePolicy #DrugPricing
www.foxnews.com
Trump's Rx plan promises savings, but economists see a hidden trade-off
Fox News senior medical analyst Dr. Marc Siegel discusses the White House's new TrumpRx initiative and efforts to reduce costs on prescription drugs on 'Fox & Friends Weekend.
#HealthcareReform #DrugPricing #HealthInsurance
www.yahoo.com
Why is US health care still the most expensive in the world after decades of cost-cutting initiatives?
Add Yahoo as a preferred source to see more of our stories on Google.
In announcing its "Great Healthcare Plan" in January 2026, the Trump administration became the latest in a long history of efforts by the U.
#DrugPricing #HealthcareReform #AffordableMedications
www.newsweek.com
How Can We Stop High Drug Prices at the Source? | Opinion
Senior Vice President, External Affairs, Blue Cross Blue Shield Association
Most Americans aren't familiar with the prescription drug supply chain, but they are familiar with the high costs of medications when they fill a prescription.
#Pharmaceuticals #DrugPricing #HealthCare
www.cbsnews.com
White House launches TrumpRx discounted drug site
Laura Doan is a fact checker for CBS News Confirmed. She covers misinformation, AI and social media.
The Trump administration launched its new TrumpRx prescription drug listing site late Thursday, part of a push by President Trump to offer lower direct-to-consumer drug prices.
#PharmacyBenefitManagers #DrugPricingReform #HealthcareTransparency
www.forbes.com
Congressional Appropriations Bills Seek To Rein In PBMs: Here's What To Know
The Senate passed a set of government funding bills on Friday that includes provisions designed to rein in intermediaries in the prescription drug supply chain called pharmacy benefit managers.
#Medicare #DrugPricing #HealthPolicy
abcnews.go.com
Trump administration announces 15 new drugs for Medicare price negotiation program
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers
NEW YORK -- Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday.
#Medicare #DrugPricing #HealthcareReform
ca.style.yahoo.com
Trump administration announces 15 new drugs for Medicare price negotiation program
Add Yahoo as a preferred source to see more of our stories on Google.
NEW YORK (AP) -- Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday.
W
#Pharmaceuticals #DrugPricing #HealthcarePolicy
www.wsj.com
Can Trump and Big Pharma Get the World to Pay More for Drugs?
President Trump claimed his 'most favored nation' policy would slash U. S. prescription costs. Krisztian Bocsi/Bloomberg
Americans pay about three times what other wealthy nations do for branded prescription drugs.
#Pharmaceuticals #DrugPricing #HealthcarePolicy
www.cnbc.com
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry
Big pharma is grappling with the impact of new drug pricing deals with President Donald Trump and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
#Pharmaceuticals #DrugPricing #HealthcarePolicy
www.cnbc.com
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry
Big pharma is grappling with the impact of new drug pricing deals with President Donald Trump and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
